In a ruling that seems to put pomegranate juice on comparable footing with pharmaceuticals, the Federal Trade Commission will require juice maker POM Wonderful to conduct extensive clinical trials before it can make any claims about the health benefits of its products.
POM Vows to Keep Fighting After FTC Backs False Advertising Claims
The National Law Journal
January 16, 2013
This article requires premium access
This article requires premium access to The AmLaw Litigation Daily. Please sign in or subscribe to read the full text.